age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
57.65399
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 2,742.049
| 2,030.5508
| null | 6
|
black
| 15.599609
| 19
| 0.914917
| 0.856934
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 63
| 6.699219
| 60
| 22
| 37.19531
| null | null | 1
| 1.399902
| 140
| null | null | null | null | null | null | null | 1.937988
| 1,142
| 1
|
45.18799
|
male
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 26
| 121,575.062
| 80,014.1875
| null | 53.666657
|
white
| 37.898438
| 63
| 0.41095
| 0.291992
| 13
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 13
| 74
| 14
| 142
| 36
| 39.59375
| 87.14062
| null | 2
| 2
| 134
| 7.40918
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 20
| 1
|
53.25098
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
$11-$25k
| 26
| 83,062.625
| 51,944.4688
| null | 38.5
|
white
| 24.898438
| 26
| 0.701904
| 0.611938
| 10
| 1
| 0
|
no
| 0.85
| 0.7
|
dnr after sadm
| 10
| 87
| 10.898438
| 92
| 8
| 37.19531
| 116.35938
| null | null | 1.5
| 145
| 7.419922
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 10
| 1
|
47.86298
|
female
| 1
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 44
| 23,279.203
| 16,235.8438
| null | 47
|
black
| 46.09375
| 59
| 0.077988
| 0.011999
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 8
| 89
| 11.599609
| 110
| 11
| 35.89844
| 157.5
| null | 39
| 3
| 152
| 7.419922
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 8
| 1
|
64.61896
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 26
|
$11-$25k
| 0
| 21,980.688
| 14,755.4375
| null | 25.5
|
white
| 20.398438
| 21
| 0.767944
| 0.518921
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 10
| 102
| 7.699219
| 78
| 32
| 38.59375
| 390
| null | 0.5
| 0.799927
| 134
| 7.419922
| null | null | null | 0
| null | null | 0.4948
| 1,876
| 0
|
25.47299
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
under $11k
| 41
| 51,170.219
| 36,150.0625
| null | 27
|
white
| 32
| 60
| 0.630981
| 0.527954
| 11
| 0
| 0
|
no
| null | null |
dnr after sadm
| 4
| 113
| 22.796875
| 134
| 52
| 39
| 423.3125
| null | null | 3.599609
| 137
| 7.329102
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 28
| 1
|
68.84595
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 13
|
>$50k
| 0
| 11,347.469
| 8,073.2383
| null | 12
|
white
| 19.199219
| 20
| 0.85498
| 0.760986
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 13
| 117
| 9.599609
| 112
| 18
| 36
| 266.625
| null | 0.399963
| 1
| 142
| 7.419922
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 764
| 1
|
66.86694
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 55
| 148,144.625
| 92,974.3125
| null | 52
|
black
| 46.296875
| 80
| 0.019997
| 0.004
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 18
| 58
| 24.296875
| 114
| 27
| 37
| 166
| null | 30
| 5.699219
| 155
| 7.40918
| null | null | null | null | null |
<2 mo. follow-up
| 3.398926
| 18
| 1
|
39.93198
|
male
| 1
| 33
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
| null | 0
| 202,703.625
| 137,771.25
| null | 36.5
|
white
| 33.796875
| 35
| 0.273987
| 0.165985
| 40
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 31
| 90
| 1
| 114
| 16
| 38
| 148.875
| 2.5
| 3.799805
| 1.5
| 142
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 33
| 1
|
66.97894
|
male
| 0
| 92
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 306,380.25
| 212,576.375
| null | 36.25
|
white
| 19.199219
| 28
| 0.813965
| 0.751953
| 14
| 0
| 0
|
no
| null | null |
no dnr
| 92
| 117
| 17.898438
| 80
| 28
| 38
| 233.3125
| null | null | 1.599854
| 133
| 7.449219
| null | null | null | null | null | null | 2.20459
| 1,873
| 0
|
75.59497
|
female
| 1
| 16
|
Lung Cancer
|
Cancer
| 1
| 10
| null | 0
| 13,365.695
| 10,269.4922
| null | 7
|
white
| 31.597656
| 20
| 0.287964
| 0.045998
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
dnr after sadm
| 3
| 91
| 7.5
| 96
| 20
| 35
| 371.375
| 2.399902
| 0.399963
| 0.799927
| 140
| 7.339844
| null | null | null | 3
| 3
|
<2 mo. follow-up
| 3
| 16
| 1
|
61.00497
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 6
| null | 0
| 3,199.719
| 2,482.4902
| null | 7
|
white
| 17.398438
| 20
| 0.902954
| 0.836914
| 1
| 0
| 0
|
no
| 0.99
| 0.85
|
no dnr
| 5
| 128
| 6.699219
| 100
| 20
| 36.5
| 257.125
| null | 0.199982
| 1.099854
| 132
| 7.40918
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.38916
| 550
| 1
|
75.65796
|
male
| 0
| 57
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 44
| 88,611.688
| 59,934.1875
| null | 22.25
|
white
| 18.898438
| 17
| 0.66394
| 0.566895
| 6
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 1
| 107
| 5.5
| 48
| 10
| 37.39844
| 323.3125
| 2.599609
| null | 0.899902
| 136
| 7.5
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 226
| 1
|
61.86697
|
male
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
>$50k
| 0
| 74,204.75
| 51,113.4062
| null | 49.5
|
white
| 47.59375
| 73
| 0.029999
| 0.007999
| 38
| 0
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 8
| 63
| 0.299988
| 146
| 17
| 36.69531
| 89.32812
| null | null | 2.799805
| 127
| 7.389648
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
80.80194
|
male
| 1
| 44
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 20
|
$25-$50k
| 55
| 133,353.125
| 88,074.3125
| null | 42
|
white
| 34
| 45
| 0.15799
| 0.076996
| 7
| 1
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 3
| 99
| 21.398438
| 110
| 10
| 36.59375
| 122.4375
| 2.399902
| 1.299805
| 5.899414
| 151
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 44
| 1
|
72.65198
|
male
| 1
| 3
|
Coma
|
Coma
| 1
| null | null | 100
| 20,842.734
| 14,142.6172
| null | 17
|
white
| 70.59375
| 78
| 0
| 0
| 4
| 0
| 0
|
no
| null | null |
dnr before sadm
| -1
| 0
| 6.199219
| 0
| 0
| 38
| 312.5
| null | null | 2.599609
| 142
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 1.836426
| 3
| 1
|
47.39999
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 15
|
>$50k
| 0
| 9,032.297
| 6,259.3008
| null | 6.5
|
white
| 15.398438
| 6
| 0.863892
| 0.695923
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 93
| 5.199219
| 68
| 24
| 37.39844
| null | null | 0.399963
| 0.5
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 461
| 1
|
76.11499
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 10
|
under $11k
| 0
| 6,222.898
| 4,641.1328
| null | 10
|
black
| 20.796875
| 32
| 0.816895
| 0.702881
| 1
| 1
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 6
| 102
| 6.699219
| 68
| 20
| 36.59375
| 508
| null | null | 3.199707
| 137
| 7.379883
| null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 804
| 1
|
43.67999
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 3,973.898
| 3,191.6055
| null | 11
|
white
| 13.099609
| 6
| 0.889893
| 0.75
| 1
| 0
| 0
|
metastatic
| 0.99
| 0.5
|
no dnr
| 5
| 95
| 7.099609
| 74
| 19
| 37.19531
| null | null | null | 1
| 138
| null | null | null | null | null | null | null | 1.622559
| 849
| 1
|
50.15997
|
female
| 1
| 89
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 144,129.25
| 96,060.75
| null | 26.75
|
black
| 24.597656
| 40
| 0.855957
| 0.761963
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
dnr after sadm
| 88
| 79
| 10.099609
| 118
| 36
| 37.5
| 428.5625
| 3.199707
| 3.199707
| 1.199951
| 138
| 7.5
| null | null | null | 0
| null |
adl>=4 (>=5 if sur)
| 0.4948
| 89
| 1
|
63.80798
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
| null | 0
| 3,234.049
| 2,703.2148
| null | 11
|
white
| 14.5
| 9
| 0.910889
| 0.849976
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 84
| 6.199219
| 90
| 20
| 36.79688
| null | null | null | 0.899902
| 141
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 384
| 1
|
41.79599
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 0
| 41,557.875
| 23,583.0469
| null | 68
|
black
| 79
| 90
| 0
| 0
| 1
| 0
| 0
|
no
| 0.3
| 0.25
|
no dnr
| 3
| 0
| 20.699219
| 0
| 0
| 39.69531
| 531
| null | 0.399963
| 7.099609
| 168
| 7.469727
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 3
| 1
|
49.94098
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 27,833.797
| 18,704.7812
| null | 21.5
|
white
| 17.296875
| 13
| 0.839966
| 0.648926
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 12
| 103
| 7.399414
| 118
| 8
| 36.5
| 370
| 3.599609
| 0.199982
| 0.899902
| 142
| 7.349609
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 797
| 1
|
66.05096
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 4,287.848
| 2,880.5723
| null | 14
|
hispanic
| 15.898438
| 9
| 0.727905
| 0.454956
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 5
| 87
| 7.899414
| 60
| 20
| 36.39844
| null | null | 0.199982
| 0.799927
| 143
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 284
| 1
|
63.82199
|
male
| 1
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 11
|
$11-$25k
| 9
| 30,126.047
| 22,027.9531
| null | 25
|
white
| 23.5
| 33
| 0.608887
| 0.50293
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.3
|
dnr after sadm
| 13
| 109
| 44.09375
| 110
| 34
| 35.89844
| 255.8125
| 3.199707
| 0.199982
| 0.799927
| 143
| 7.439453
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 15
| 1
|
60.01599
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 44
| 29,811.031
| 19,366.2188
| null | 53
|
white
| 50.398438
| 98
| 0.001
| 0
| 8
| 1
| 0
|
yes
| 0.01
| 0.000001
|
dnr after sadm
| 4
| 44
| 0.099991
| 180
| 12
| 37.29688
| 252.5
| 1.899902
| 4.699219
| 3.799805
| 153
| 7.289062
| null | null | null | null | null |
<2 mo. follow-up
| 2.475098
| 4
| 1
|
71.75598
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 9
| 59,008.219
| 39,635.0312
| null | 23.333328
|
black
| 27.597656
| 38
| 0.60791
| 0.501953
| 11
| 0
| 0
|
no
| 0.85
| 0.82
|
no dnr
| 16
| 63
| 24.796875
| 110
| 18
| 36.39844
| 170
| 2.599609
| 0.899902
| 2.099609
| 140
| 7.5
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 270
| 1
|
39.34598
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| null | null | null | 23
|
black
| 25.199219
| 36
| 0.856934
| 0.806885
| 2
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 13
| 114
| 20
| 118
| 40
| 37
| 442.8125
| null | 2.299805
| 1.199951
| 146
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,856
| 0
|
66.22595
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 17
| null | 0
| 34,187.938
| 24,100.2969
| null | 9.333328
|
white
| 25.296875
| 18
| 0.715942
| 0.628906
| 14
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 17
| 108
| 8.798828
| 70
| 26
| 35.59375
| 142.84375
| null | null | 0.5
| 138
| 7.30957
| null | null | null | null | 6
|
adl>=4 (>=5 if sur)
| 6
| 708
| 1
|
29.55499
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 51,709.438
| 33,807.0938
| null | 59
|
black
| 48.5
| 74
| 0.349976
| 0.232971
| 10
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 5
| 47
| 18.398438
| 112
| 30
| 35.89844
| 90
| null | 3.599609
| 5.799805
| 142
| 7.529297
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 6
| 1
|
69.90594
|
male
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$25-$50k
| 0
| 4,728.047
| 3,503.3516
| null | 14
|
white
| 17.898438
| 20
| 0.766968
| 0.629883
| 1
| 0
| 0
|
no
| 0.85
| 0.5
|
no dnr
| 5
| 81
| 9.199219
| 80
| 18
| 37.29688
| null | 3.199707
| 6.099609
| 1
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 929
| 1
|
56.97998
|
male
| 0
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 29,052.234
| 19,552.2812
| null | 15.666664
|
white
| 26
| 38
| 0.644897
| 0.544922
| 2
| 0
| 0
|
yes
| 0.8
| 0.5
|
no dnr
| 18
| 89
| 100
| 90
| 36
| 38.79688
| 133.3125
| null | null | 1.599854
| 137
| 7.459961
| null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 127
| 1
|
57.81497
|
male
| 1
| 22
|
Lung Cancer
|
Cancer
| 1
| 10
|
$25-$50k
| 0
| 23,437.938
| 16,626.1875
| null | 11.666664
|
white
| 26
| 10
| 0.511963
| 0.190979
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.001
|
dnr after sadm
| 11
| 88
| 19.097656
| 100
| 18
| 36
| null | 2.899902
| 0.199982
| 0.899902
| 136
| null | null | null | null | 1
| 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
61.32498
|
male
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 61
| 33,008.531
| 24,771.1094
| null | 29
|
white
| 19
| 22
| 0.488953
| 0.370972
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 3
| 131
| 15.599609
| 48
| 8
| 37.29688
| 302.8125
| 2.699707
| 0.299988
| 1.299805
| 146
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 2.858398
| 25
| 1
|
76.11798
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 5,847.648
| 4,985.293
| null | 9
|
white
| 16.5
| 25
| 0.865967
| 0.778931
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 97
| 4.199219
| 74
| 20
| 35.79688
| null | 4
| 2.099609
| 1.799805
| 140
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 510
| 1
|
72.94995
|
female
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 3
| null | 0
| 73,442.438
| 46,502.6562
| null | 36
|
black
| 19.296875
| 31
| 0.831909
| 0.773926
| 2
| 1
| 0
|
no
| null | null |
dnr after sadm
| 10
| 65
| 7.899414
| 110
| 8
| 37.89844
| 356.625
| 2.5
| 0.399963
| 1.799805
| 132
| 7.40918
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
26.92699
|
male
| 1
| 35
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
under $11k
| 0
| 141,803.25
| 94,806
| null | 34
|
other
| 40.195313
| 70
| 0.61499
| 0.509888
| 7
| 0
| 0
|
no
| 0.1
| 0.001
|
dnr after sadm
| 34
| 67
| 16.796875
| 140
| 36
| 37.5
| 130
| 2.799805
| 5.5
| 5.399414
| 134
| 7.289062
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 35
| 1
|
77.05396
|
female
| 1
| 5
|
Coma
|
Coma
| 2
| null | null | 100
| 9,438.594
| 7,084.5703
| null | 25
|
black
| 18.898438
| 32
| 0.230988
| 0.165985
| 1
| 1
| 1
|
no
| null | null |
dnr after sadm
| 4
| 131
| 12.798828
| 112
| 10
| 39.09375
| 366.625
| null | 0.299988
| 0.799927
| 142
| 7.459961
| null | null | null | null | null |
<2 mo. follow-up
| 4.424805
| 5
| 1
|
71.52594
|
male
| 1
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 7
|
$11-$25k
| 41
| 238,583.125
| 160,377.875
| null | 32.5
|
white
| 26.898438
| 38
| 0.442993
| 0.323975
| 43
| 1
| 0
|
no
| 1
| 1
|
dnr after sadm
| 48
| 80
| 6.299805
| 110
| 39
| 36.09375
| 287.5
| 2.5
| 0.399963
| 2
| 152
| 7.399414
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 53
| 1
|
43.31799
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 0
| 16
|
$25-$50k
| 0
| 3,554.6
| 2,829.8418
| null | 9
|
white
| 26.199219
| 32
| 0.789917
| 0.662964
| 1
| 0
| 0
|
no
| 0.95
| 0.6
|
no dnr
| 6
| 103
| 8.5
| 76
| 20
| 36.69531
| 438.0625
| 3
| 6.099609
| 1.699951
| 126
| 7.40918
| null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 19
| 1
|
63.12399
|
female
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 44
| 80,263.875
| 54,229.2812
| null | 37.333313
|
white
| 27.398438
| 47
| 0.535889
| 0.420959
| 5
| 0
| 0
|
no
| null | null |
dnr after sadm
| 14
| 87
| 0.799927
| 76
| 10
| 36.59375
| 293.3125
| 2.5
| null | 7.399414
| 136
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 14
| 1
|
72.03595
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 0
| null | null | null | 10
|
white
| 23.097656
| 44
| 0.781982
| 0.710938
| 2
| 1
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 23
| 123
| 11.699219
| 78
| 25
| 35.89844
| 310
| null | null | 2.099609
| 136
| 7.399414
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 923
| 1
|
71.79199
|
female
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 61
| 48,463.688
| 32,859.2812
| null | 38.5
|
white
| 38.195313
| 67
| 0.008999
| 0.001
| 9
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 6
| 63
| 7.099609
| 110
| 25
| 36
| 220
| 2.799805
| 15.298828
| 3.599609
| 130
| 7.449219
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
65.97894
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 2
| 7
| null | 0
| 13,066.297
| 9,421.9062
| null | 10
|
white
| 14.398438
| 13
| 0.754883
| 0.498962
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 12
| 105
| 7.799805
| 74
| 18
| 36.59375
| null | null | 0.299988
| 0.699951
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 421
| 1
|
66.15698
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 3,142.35
| 2,077.5918
| null | 8
|
white
| 16.097656
| 9
| 0.721924
| 0.44696
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 99
| 3.899902
| 88
| 20
| 36
| null | null | 0.199982
| 0.799927
| 135
| null | null | null | null | null | null | null | 1.993897
| 78
| 1
|
67.74298
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 18
|
$11-$25k
| 0
| 3,384.398
| 3,038.7207
| null | 7
|
white
| 17.699219
| 13
| 0.876953
| 0.794922
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 8
| 93
| 6.399414
| 54
| 20
| 36.09375
| null | null | 0.799927
| 1.299805
| 140
| null | null | null | null | 0
| 0
| null | 0
| 1,530
| 1
|
58.48599
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 3,006.998
| 2,284.6152
| null | 12
|
white
| 16.597656
| 15
| 0.730957
| 0.458984
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 2
| 81
| 7.799805
| 100
| 16
| 38.09375
| 238.09375
| null | 0.5
| 0.599976
| 135
| 7.299805
| null | null | null | null | null | null | 2.708496
| 60
| 1
|
59.75098
|
male
| 0
| 245
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 2
|
under $11k
| 37
| 405,592
| 275,511.75
| null | 49.5
|
white
| 18.796875
| 27
| 0.767944
| 0.692993
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 245
| 98
| 9.298828
| 104
| 8
| 40
| 292.5
| 3.299805
| null | 1.399902
| 142
| 7.5
| null | null | null | null | null | null | 2.061035
| 1,846
| 0
|
87.52899
|
male
| 1
| 3
|
Coma
|
Coma
| 0
| null | null | 100
| 9,511.203
| 6,827.6094
| null | 27
|
black
| 71
| 74
| 0
| 0
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 3
| 0
| 9.298828
| 0
| 0
| 36.59375
| 260
| 4.199219
| 0.399963
| 2.299805
| 141
| 7.379883
| null | null | null | null | null |
<2 mo. follow-up
| 2.178223
| 3
| 1
|
43.09097
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 9,515.945
| 7,197.6836
| null | 13
|
white
| 17
| 11
| 0.930908
| 0.881958
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 11
| 101
| 9.199219
| 86
| 20
| 35.79688
| 819
| null | 1.399902
| 1.099854
| 135
| 7.489258
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,358
| 1
|
76.06598
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 2,045.55
| 1,734.7861
| null | 7
|
white
| 22.5
| 35
| 0.791992
| 0.665894
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 79
| 8.898438
| 64
| 16
| 35.59375
| 285.6875
| null | null | 2.599609
| 138
| 7.419922
| null | null | null | null | null | null | 2.812988
| 486
| 1
|
67.64398
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 16
|
$25-$50k
| 0
| 6,064.5
| 3,969.1719
| null | 14
|
white
| 13.699219
| 11
| 0.762939
| 0.510986
| 1
| 0
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 6
| 93
| 9.699219
| 68
| 18
| 36.79688
| null | null | 0.299988
| 1
| 139
| null | null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 172
| 1
|
56.06299
|
female
| 1
| 25
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 18
|
>$50k
| 0
| 141,836.875
| 94,576.6875
| null | 36.75
|
asian
| 24.097656
| 33
| 0.746948
| 0.601929
| 1
| 0
| 0
|
no
| 0.6
| 0.4
|
dnr after sadm
| 19
| 81
| 7
| 84
| 20
| 36.5
| null | 2.599609
| 21.5
| 1.299805
| 135
| null | null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 25
| 1
|
77.01599
|
female
| 0
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| null | null | null | 21
|
white
| 23.898438
| 40
| 0.616943
| 0.511963
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 9
| 113
| 34.796875
| 110
| 10
| 36.79688
| 400
| 1.399902
| null | 1
| 131
| 7.429688
| null | null | null | null | null | null | 3.42334
| 1,844
| 0
|
45.67297
|
male
| 0
| 14
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 10,358.094
| 8,390.8359
| null | 8
|
white
| 14.798828
| 8
| 0.904907
| 0.839966
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 14
| 85
| 4.399414
| 86
| 24
| 36.69531
| 374.9375
| 2.799805
| 0.799927
| 0.699951
| 141
| 7.389648
| null | null | null | null | null | null | 2.809082
| 346
| 1
|
74.29395
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 7
|
under $11k
| 0
| 19,400.234
| 13,264.3281
| null | 25
|
white
| 20.199219
| 38
| 0.805908
| 0.741943
| 3
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 9
| 67
| 25.097656
| 66
| 16
| 36.69531
| 194.28125
| null | 0.599976
| 1.599854
| 141
| 7.449219
| null | null | null | 0
| 5
|
no(M2 and SIP pres)
| 5
| 453
| 1
|
59.91498
|
male
| 0
| 28
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 51,688.625
| 36,456.1875
| null | 28.75
|
black
| 36.296875
| 102
| 0.269958
| 0.162994
| 2
| 0
| 0
|
metastatic
| 0.25
| 0.15
|
dnr after sadm
| 4
| 60
| 0.899902
| 200
| 35
| 39
| 277
| 2.299805
| 1.799805
| 3.699707
| 140
| 7.179688
| null | null | null | 0
| 0
| null | 0
| 301
| 1
|
73.57697
|
male
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 24
|
>$50k
| 0
| 13,001.945
| 8,862.6719
| null | 15
|
white
| 19.199219
| 16
| 0.766968
| 0.517944
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 9
| 97
| 13.199219
| 66
| 12
| 36.69531
| 436
| null | 0.699951
| 0.799927
| 133
| 7.399414
| null | null | null | null | null | null | 2.433594
| 1,840
| 0
|
56.09598
|
female
| 0
| 66
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 182,209.5
| 122,078.812
| null | 32
|
other
| 23.699219
| 22
| 0.846924
| 0.748901
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 66
| 67
| 8
| 120
| 16
| 37.09375
| 356.625
| null | 1.5
| 0.899902
| 127
| 7.5
| null | null | null | 5
| 5
|
SIP>=30
| 5
| 1,826
| 0
|
49.43997
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 5,030.449
| 3,832.707
| null | 13
|
hispanic
| 15.099609
| 5
| 0.863892
| 0.696899
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 83
| 8.298828
| 72
| 18
| 36.39844
| null | null | 1
| 0.899902
| 135
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 128
| 1
|
40.81598
|
male
| 0
| 207
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 16
|
$25-$50k
| 0
| 548,741.5
| 357,946.75
| null | 23
|
white
| 18.699219
| 17
| 0.92395
| 0.871948
| 1
| 0
| 0
|
no
| 0.15
| 0.1
|
no dnr
| 207
| 63
| 7.899414
| 114
| 16
| 36.79688
| null | null | 1.199951
| 1
| 135
| null | null | null | null | 0
| 0
|
SIP>=30
| 0
| 1,825
| 0
|
38.19299
|
male
| 0
| 24
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 16,639.641
| 13,194.3906
| null | 7
|
white
| 30.296875
| 40
| 0.754883
| 0.611938
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 24
| 89
| 4.899414
| 80
| 12
| 36.5
| 240
| 2.799805
| 5.599609
| 1.899902
| 123
| 7.5
| null | null | null | 2
| 0
|
SIP>=30
| 0
| 290
| 1
|
62.46997
|
male
| 1
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$25-$50k
| 0
| 26,328.797
| 18,009.0938
| null | 31
|
white
| 19.796875
| 16
| 0.870972
| 0.785889
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 10
| 69
| 11.699219
| 80
| 20
| 36.79688
| 180
| null | 1.899902
| 1.099854
| 133
| 7.489258
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 13
| 1
|
41.09799
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 5,966.547
| 4,505.6875
| null | 6.5
|
white
| 25.597656
| 12
| 0.575928
| 0.254944
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 8
| 86
| 8.199219
| 116
| 24
| 38.09375
| 366.625
| 2.799805
| 0.599976
| 0.699951
| 138
| 7.459961
| null | null | null | null | null | null | 3.006348
| 91
| 1
|
73.81
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 9
| 17,738.891
| 13,056.7734
| null | 14.333328
|
black
| 22.699219
| 20
| 0.755981
| 0.613892
| 1
| 0
| 1
|
no
| 0.5
| 0.3
|
no dnr
| 14
| 113
| 6.699219
| 114
| 12
| 36.29688
| 228.5625
| 2.899902
| null | 0.899902
| 139
| 7.349609
| null | null | null | null | null | null | 5.594727
| 1,824
| 0
|
38.36298
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 15,814.742
| 12,230.4922
| null | 16
|
white
| 25.097656
| 53
| 0.869995
| 0.824951
| 1
| 1
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 9
| 116
| 15.798828
| 82
| 26
| 36.5
| 176.65625
| 1.799805
| 0.299988
| 2.699707
| 137
| 7.5
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,823
| 0
|
59.20099
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 121,286.188
| 78,953.375
| null | 23
|
white
| 38.59375
| 50
| 0.40094
| 0.280945
| 39
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 1
| 63
| 12.099609
| 122
| 36
| 35.79688
| 195.90625
| null | null | 2.5
| 124
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 2.017578
| 7
| 1
|
62.64999
|
male
| 1
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| null | null | null | 46.333313
|
white
| 20
| 31
| 0.861938
| 0.813965
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 16
| 121
| 13.099609
| 110
| 20
| 38.59375
| 215.53125
| null | 0.399963
| 1.5
| 141
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 18
| 1
|
70.46997
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 6
| null | 0
| 5,841.199
| 4,553.0547
| null | 8
|
black
| 14.5
| 14
| 0.892944
| 0.821899
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 7
| 83
| 11.398438
| 80
| 18
| 37
| 273.3125
| null | null | 1
| 141
| 7.139648
| null | null | null | 0
| 1
| null | 1
| 439
| 1
|
64.01099
|
female
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 2,651.699
| 1,935.8984
| null | 11
|
white
| 15.699219
| 17
| 0.904907
| 0.840942
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 4
| 63
| 4.5
| 80
| 22
| 36.19531
| 328.5625
| 3.399902
| 0.799927
| 0.899902
| 145
| 7.359375
| null | null | null | 4
| 6
|
no(M2 and SIP pres)
| 6
| 1,821
| 0
|
23.07999
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 100
| 12,763.844
| 9,594.2344
| null | 24
|
black
| 16.199219
| 17
| 0.809937
| 0.745972
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 106
| 7
| 72
| 32
| 39
| 205.6875
| null | 0.299988
| 1
| 134
| 7.399414
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.512695
| 1,820
| 0
|
75.58398
|
male
| 1
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 91,257.875
| 62,239.5938
| null | 42
|
white
| 40.195313
| 80
| 0.14798
| 0.070999
| 11
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 17
| 123
| 0.099991
| 124
| 37
| 38.5
| 410
| null | 5
| 4.799805
| 145
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
63.28
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 3,109.75
| 2,196.4746
| null | 3
|
white
| 16.097656
| 16
| 0.72998
| 0.458984
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 4
| 103
| 4.799805
| 100
| 20
| 36.29688
| null | null | 0.299988
| 1
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 194
| 1
|
50.47198
|
female
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 59,530.938
| 40,604.875
| null | 16.25
|
white
| 23.398438
| 28
| 0.846924
| 0.794922
| 2
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 31
| 120
| 14.798828
| 124
| 32
| 39.09375
| 226.65625
| null | null | 0.699951
| 142
| 7.479492
| null | null | null | null | null | null | 2.425293
| 1,818
| 0
|
26.53499
|
female
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 17
|
under $11k
| 37
| 43,313.031
| 27,733.25
| null | 33
|
white
| 69.6875
| 62
| 0
| 0
| 15
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 0
| 50.09375
| 0
| 0
| 38.89844
| 252.5
| 2.099609
| 1.799805
| 0.899902
| 146
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
67.88794
|
male
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 26
| 34,118.438
| 23,141.9219
| null | 33
|
white
| 33.296875
| 42
| 0.417969
| 0.217987
| 1
| 0
| 0
|
yes
| 0.2
| 0.2
|
no dnr
| 12
| 121
| 14.798828
| 146
| 9
| 39.39844
| 150
| 2.599609
| 0.399963
| 0.599976
| 134
| 7.299805
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
76.24896
|
male
| 1
| 29
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 99,316.812
| 67,983.5
| null | 40.25
|
black
| 25.796875
| 42
| 0.708984
| 0.54895
| 1
| 1
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 29
| 143
| 6.199219
| 180
| 12
| 36.59375
| 285.6875
| 2.299805
| 0.199982
| 1
| 138
| 7.389648
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 29
| 1
|
60.28699
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 3
| 6
|
>$50k
| 0
| 6,261.598
| 4,410.7773
| null | 7
|
white
| 20.597656
| 22
| 0.643921
| 0.335999
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 7
| 104
| 9.898438
| 72
| 26
| 38.29688
| null | 3
| 0.299988
| 1.399902
| 135
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 99
| 1
|
49.26199
|
female
| 1
| 26
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
>$50k
| 0
| 178,246.625
| 116,131.625
| null | 43
|
white
| 37.195313
| 40
| 0.263977
| 0.15799
| 16
| 0
| 0
|
yes
| 0.7
| 0.5
|
dnr after sadm
| 23
| 131
| 1.099854
| 138
| 29
| 39.89844
| 230
| 2.599609
| 6.799805
| 0.699951
| 134
| 7.429688
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
62.26999
|
female
| 1
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
|
$11-$25k
| 41
| 89,426.625
| 60,591.3438
| null | 31.5
|
black
| 36.59375
| 69
| 0.362
| 0.244995
| 1
| 0
| 0
|
no
| 0.2
| 0.15
|
no dnr
| 30
| 59
| 11.298828
| 124
| 45
| 39.09375
| 128.3125
| 2.699707
| null | 2.099609
| 158
| 7.459961
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 30
| 1
|
62.004
|
female
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 14,802.898
| 10,652.4844
| null | 25
|
white
| 36.296875
| 37
| 0.391968
| 0.195984
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 10
| 47
| 12.798828
| 64
| 16
| 34.69531
| 110.20312
| 2.099609
| 0.399963
| 0.699951
| 141
| 7.439453
| null | null | null | null | null | null | 3.069336
| 1,814
| 0
|
48.32898
|
male
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 3,862.049
| 2,818.4746
| null | 7
|
black
| 18.597656
| 31
| 0.929932
| 0.880981
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 81
| 4.699219
| 80
| 28
| 36.79688
| 190.46875
| 3.199707
| 0.5
| 0.899902
| 142
| 7.279297
| null | null | null | null | null | null | 2.43457
| 638
| 1
|
70.23096
|
female
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 61,871.781
| 42,937.25
| null | 31
|
white
| 18.597656
| 27
| 0.8479
| 0.795898
| 2
| 0
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 27
| 63
| 14.199219
| 72
| 24
| 36.69531
| 211.40625
| null | null | 1.5
| 136
| 7.419922
| null | null | null | 1
| 1
|
<2 mo. follow-up
| 1
| 51
| 1
|
66.297
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 5,967
| 4,048.7168
| null | 12
|
white
| 10.099609
| 6
| 0.889893
| 0.747925
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 6
| 97
| 7.299805
| 100
| 16
| 37.59375
| null | 4
| 0.299988
| 0.699951
| 141
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 317
| 1
|
69.62396
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 0
| 38,503.188
| 27,377.5
| null | 25
|
white
| 29.597656
| 41
| 0.655884
| 0.556885
| 3
| 0
| 0
|
no
| 0.5
| 0.25
|
no dnr
| 15
| 67
| 12.5
| 110
| 14
| 38.59375
| 120.40625
| null | null | 2.199707
| 144
| 7.509766
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 143
| 1
|
54.409
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
>$50k
| 0
| 4,717.898
| 3,261.6523
| null | 11
|
white
| 13.798828
| 18
| 0.931885
| 0.883911
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 78
| 6.5
| 84
| 18
| 36.79688
| null | 4.299805
| 4
| 0.699951
| 146
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,812
| 0
|
52.03598
|
female
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 21
| null | 0
| 4,229.547
| 2,943.043
| null | 13
|
white
| 19.597656
| 16
| 0.805908
| 0.585938
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 5
| 105
| 5.099609
| 120
| 20
| 39
| null | null | 0.5
| 0.599976
| 142
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 387
| 1
|
63.33499
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 8
|
$25-$50k
| 0
| 5,371.25
| 3,912.6953
| null | 9
|
white
| 28.398438
| 30
| 0.606934
| 0.290955
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 6
| 47
| 5.099609
| 60
| 12
| 35.09375
| null | null | 0.5
| 0.899902
| 140
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 396
| 1
|
20.605
|
female
| 0
| 90
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 152,497.25
| 102,769.375
| null | 29.25
|
black
| 30
| 39
| 0.852905
| 0.80188
| 2
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 90
| 77
| 6.199219
| 40
| 8
| 36.19531
| 187.5
| null | 3.099609
| 2.099609
| 147
| 7.509766
| null | null | null | null | 0
| null | 0
| 92
| 1
|
62.52698
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 22
|
$25-$50k
| 0
| 2,618.5
| 2,440.3203
| null | 4.5
|
white
| 15.898438
| 22
| 0.903931
| 0.838989
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 7
| 79
| 4.699219
| 70
| 18
| 36
| null | null | 0.899902
| 1.299805
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,302
| 1
|
53.81
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 7
|
under $11k
| 0
| 4,520.699
| 3,556.5644
| null | 10
|
black
| 16.597656
| 11
| 0.915894
| 0.856934
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 85
| 6
| 78
| 22
| 36.09375
| 368
| null | 1.5
| 1
| 133
| 7.459961
| null | null | null | 4
| null | null | 3.183199
| 589
| 1
|
42.24799
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 13
|
$11-$25k
| 0
| 18,666.984
| 13,877.7188
| null | 22.5
|
black
| 31.796875
| 38
| 0.789917
| 0.662964
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 11
| 47
| 4.599609
| 112
| 28
| 35.39844
| 224
| null | 1.5
| 1
| 134
| 7.489258
| null | null | null | 5
| 0
| null | 0
| 201
| 1
|
52.13998
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6
| 14
|
under $11k
| 0
| null | null | null | 16.666656
|
white
| 27.296875
| 51
| 0.727905
| 0.643921
| 3
| 0
| 0
|
yes
| 0.9
| 0.85
|
no dnr
| 19
| 163
| 5.5
| 118
| 38
| 37.79688
| 245.6875
| null | 0.199982
| 5.299805
| 140
| 7.479492
| null | null | null | null | 6
|
no(M2 and SIP pres)
| 6
| 1,811
| 0
|
69.08398
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 95,429.812
| 60,088.8125
| null | 42
|
black
| 30.199219
| 46
| 0.41095
| 0.291992
| 13
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 7
| 76
| 27.199219
| 118
| 10
| 36.09375
| 363.3125
| null | 2.199707
| 2.399902
| 152
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.517578
| 7
| 1
|
63.35699
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 15,985.195
| 11,313.6406
| null | 23.5
|
black
| 35.59375
| 55
| 0.586914
| 0.477966
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 57
| 4
| 148
| 24
| 35.89844
| 352.375
| null | 1.899902
| 2.699707
| 132
| 7.439453
| null | null | null | null | null | null | 2.844238
| 89
| 1
|
83.24194
|
female
| 0
| 15
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 16,066.695
| 12,339.7422
| null | 15.666664
|
black
| 23.597656
| 24
| 0.740967
| 0.592896
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 15
| 83
| 5.799805
| 60
| 16
| 36
| 163.25
| null | 2.699707
| 1.5
| 140
| 7.359375
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 85
| 1
|
57.28699
|
female
| 0
| 22
|
Lung Cancer
|
Cancer
| 1
| 10
|
$11-$25k
| 0
| 23,456.391
| 16,489.7344
| null | 11
|
white
| 20.898438
| 21
| 0.644897
| 0.337952
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 22
| 76
| 9.199219
| 108
| 28
| 36.29688
| 319
| null | 0.699951
| 0.699951
| 143
| 7.399414
| null | null | null | 6
| null | null | 4.527397
| 322
| 1
|
46.65799
|
female
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
| null | 44
| 39,171.875
| 28,236.4219
| null | 23
|
black
| 26.597656
| 50
| 0.661987
| 0.564941
| 4
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 19
| 145
| 17.699219
| 110
| 32
| 38.59375
| 376.1875
| null | 1.099854
| 8.199219
| 132
| 7.419922
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,806
| 0
|
42.935
|
male
| 1
| 7
|
Coma
|
Coma
| 0
| null | null | 100
| 21,663.938
| 14,849.8281
| null | 30.5
|
black
| 17.398438
| 12
| 0.569946
| 0.50293
| 3
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 78
| 17
| 54
| 12
| 38
| 323.3125
| null | null | 0.799927
| 142
| 7.5
| null | null | null | null | null |
<2 mo. follow-up
| 2.086914
| 7
| 1
|
65.24597
|
male
| 0
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 9
| 18,175.234
| 14,276.125
| null | 13
|
white
| 26.699219
| 25
| 0.522949
| 0.406982
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.1
|
no dnr
| 9
| 103
| 14.898438
| 64
| 12
| 36.5
| 116
| null | 0.599976
| 0.699951
| 136
| 7.489258
| null | null | null | null | null |
<2 mo. follow-up
| 3.376953
| 15
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.